The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Trimel Pharmaceuticals

  • TRL
  • TSX
  • Consumer Products
  • Latest 0.63
  • Currency C$
  • Change 0.0000
  • Percent Change 0.00 %
  • Volume 0
  • Thu Apr 17, 2014 04:15 PM EDT TSX data delayed 15 minutes.
  • Open 0.0000
  • Previous Close 0.63
  • High 0.0000
  • Low 0.0000
  • Bidx16,500 0.66
  • Askx8,500 0.66
  • 52-week High05/01 1.24
  • 52-week Low12/23 0.335
  • Beta -19.165
  • Market Cap 93.43M
  • EPS -0.28
  • P/E
  • Forward P/E
  • PEG
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $703,015
  • Earnings $-29,522,256
  • Return on Equity n/a

Cash Flow

  • Cash Flow $-25,355,685
  • Cash $24,033,239
  • Current Ratio 4.77

12 months ended Sep 30, 2013.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $33,142,516
  • Liabilities $8,328,229
  • Liabilities-to-Equity Ratio 0.34

Price Ratios

  • Price to Sales 132.89
  • Price to Book 3.71
  • Price to Cash Flow -3.68

Event Calendar

Event Last   Next  
Earnings Aug 8 $-0.04 May 14 $-0.04
Surprises Aug 8 100.00% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Apr 21, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

TRIMEL PHARMACEUTICALS CORPORATION is a pharmaceutical company developing medications for male hypogonadism, female sexual dysfunction and various respiratory disorders.

Related Securities
Symbol Type Latest % Chg

Officers

  • Tom Rossi President & C.E.O.
  • Kenneth Howling C.F.O.
  • Company Type: PUBLIC
  • Company Status: Active
  • Full-time Employees: 27
  • Incorporation: Canada,
    Jul 15, 2009
  • Top 1000 Ranking: Profit: 0
    Revenue: 0
    Assets: 0

Head Office

2488 Dunwin Drive
Mississauga, ON
L5L 1J9

Phone: (416)-679-0771
Fax: (905)-5691809

ir@trimelpharmaceuticals.com
www.trimelpharmaceuticals.com

Ideas & Discussion

Live Discussion of TRL on StockTwits